Cite
MLA Citation
I Martin Nuñez et al.. “CP-103 Subcutaneous single-use injection device and intravenous formulations in patients with HER2-positive early breast cancer.” European journal of hospital pharmacy, vol. 21, n.d., pp. A41–A42. http://access.bl.uk/ark:/81055/vdc_100135153993.0x000001